Tandem Diabetes Care, Inc. (TNDM) Gross margin 2016–2025
Tandem Diabetes Care, Inc. (TNDM) gross margin by fiscal year — reported gross profit divided by reported revenue.
53.8%FY2025 · since FY2016: 28.0% → 53.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 53.8% | +1.7 pp |
| FY2024 | 52.1% | +2.9 pp |
| FY2023 | 49.2% | -2.4 pp |
| FY2022 | 51.5% | -2.0 pp |
| FY2021 | 53.5% | +1.3 pp |
| FY2020 | 52.2% | -1.4 pp |
| FY2019 | 53.6% | +4.8 pp |
| FY2018 | 48.9% | +7.9 pp |
| FY2017 | 41.0% | +13.0 pp |
| FY2016 | 28.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNDM financial trends
TNDM RevenueTNDM Net incomeTNDM Net marginTNDM Gross profitTNDM Operating incomeTNDM Operating marginTNDM Operating cash flowTNDM Free cash flowTNDM Capital expendituresTNDM Return on equityTNDM Stock buybacksTNDM Dividends paidTNDM Total assetsTNDM Total liabilitiesTNDM Shareholders’ equityTNDM overview →